We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Smallpox Vaccine Effective for Monkeypox

By Biotechdaily staff writers
Posted on 23 Aug 2005
Researchers using a sensitive immunoassay to study the 2003 outbreak of monkeypox in the United States have found that while 72 cases had been reported, the actual number of individuals who contracted the disease was probably much greater, since those who had been vaccinated against smallpox did not develop symptoms of monkeypox.

Investigators at the Oregon Health & Science University (Beaverton, OR, USA) tested sera from individuals exposed to monkeypox during the 2003 Wisconsin outbreak. More...
Those who had contracted the disease, whether or not they became ill, were detected with a highly accurate enzyme-linked immunosorbent assay (ELISA) that demonstrated 95% sensitivity and 90% specificity.

Results published in the August 7, 2005, online edition of Nature Medicine indicated that the 2003 monkeypox outbreak probably extended beyond the officially recognized 72 cases. This conclusion was based on the identification of three previously unreported cases of monkeypox in individuals at 13, 29, and 48 years after smallpox vaccination. These individuals were unaware that they had been infected because they did not experience any recognizable disease symptoms.

"Our research demonstrates that the limitations of currently used technology likely allowed monkeypox cases to slip through the system. This problem was further exacerbated by the two-week delay that occurred during the diagnosis of the first monkeypox cases,” explained senior author Dr. Mark Slifka, assistant professor of molecular microbiology and immunology at Oregon Health & Science University. "If the 2003 outbreak had been smallpox instead of monkeypox, the situation could have been much worse because secondary spread of the virus to other victims would likely have occurred before the outbreak was recognized.”



Related Links:
Oregon Health & Science Univ

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Automated Clinical Chemistry Analyzer
Envoy 500+
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: Schematic overview of the CRISPR-Assisted Nanodroplet-pairing Platform for Differential Identification of NTM (CANDI). The platform combines broad-range amplification using conserved regions of the 16S and 23S rRNA genes with species-specific CRISPR recognition. Fluorescence-coded CRISPR droplets are paired with sample droplets containing amplified products, enabling multiplexed target recognition and signal decoding (Image Credit: Yiwen Yang, Jingsong Xu, Dakang Xu)

Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.